Alpha Tau Medical LTD

Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., sold 17,730 shares of common stock on August 11, 2026 for $14.00 per share.

Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., reported transactions involving ordinary shares on July 6, 2026.

Alpha Tau Medical Ltd. Chief Financial Officer, Raphi Levy, reported transactions involving the acquisition and disposition of ordinary shares.

Alpha Tau Medical Ltd. Chief Financial Officer, Raphi Levy, reports transactions involving ordinary shares, including acquisitions and dispositions.

Alpha Tau Medical Ltd. reports a transaction by its Chief Financial Officer, Raphi Levy, involving the purchase of 20,000 ordinary shares.

Alpha Tau Medical Ltd. CFO Raphi Levy reported a sale of 20,000 ordinary shares on June 25, 2026, for a total transaction value of $220,000.

Oramed Pharmaceuticals Inc. and its subsidiary Oramed Ltd. have acquired a 19.99% beneficial ownership in Alpha Tau Medical Ltd. through a $36.9 million share purchase and entered into a strategic investor relations and public relations services agreement.

Uzi Sofer, a citizen of Israel, has disclosed a beneficial ownership of 15.8% of Alpha Tau Medical Ltd.'s Ordinary Shares as of December 31, 2022.